Treatment of NSCLC cell lines (i.e. A549 and H2122) with PRMT1-specific siRNAs suppressed the expression of PRMT1 by more than 70% (Fig. 1, B–E). Here, PRMT1 is linked to non-small cell lung carcinoma.